Newbridge Financial Services Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.9K Hold
110
﹤0.01% 855
2025
Q4
$10.5K Sell
110
-350
-76% -$34.3K ﹤0.01% 772
2025
Q3
$44.9K Sell
460
-16,300
-97% -$1.69M 0.01% 536
2025
Q2
$1.8M Sell
16,760
-457
-3% -$46.2K 0.29% 71
2025
Q1
$1.74M Sell
17,217
-130
-0.7% -$13.1K 0.42% 54
2024
Q4
$1.55M Buy
17,347
+1,975
+13% +$174K 0.4% 54
2024
Q3
$1.29M Buy
15,372
+6,240
+68% +$492K 0.45% 53
2024
Q2
$703K Buy
9,132
+8,717
+2,100% +$638K 0.26% 76
2024
Q1
$28.4K Buy
+415
New +$26.7K 0.01% 529
2023
Q4
Sell
-170
Closed -$8.98K 1188
2023
Q3
$8.98K Hold
170
﹤0.01% 846
2023
Q2
$9.2K Hold
170
﹤0.01% 901
2023
Q1
$8.51K Hold
170
﹤0.01% 939
2022
Q4
$7.87K Hold
170
﹤0.01% 964
2022
Q3
$7K Sell
170
-249
-59% -$9.99K ﹤0.01% 963
2022
Q2
$16K Sell
419
-1,245
-75% -$50.7K 0.01% 718
2022
Q1
$74K Hold
1,664
0.04% 369
2021
Q4
$71K Hold
1,664
0.03% 374
2021
Q3
$72K Sell
1,664
-436
-21% -$19.3K 0.05% 323
2021
Q2
$90K Buy
2,100
+422
+25% +$17.8K 0.06% 300
2021
Q1
$65K Sell
1,678
-688
-29% -$26K 0.05% 337
2020
Q4
$85K Sell
2,366
-2,177
-48% -$78.5K 0.07% 240
2020
Q3
$174K Buy
+4,543
New +$175K 0.17% 124

Other funds holding BSX